Currency in USD
Earnings estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 4 | 2 | 4 | 5 |
Avg. Estimate | -0.02 | -0.03 | -0.05 | 0.07 |
Low estimate | -0.04 | -0.09 | -0.08 | -0.25 |
High estimate | 0 | 0.02 | -0.04 | 0.28 |
Year ago EPS | 0.34 | 0.03 | 0.06 | -0.05 |
Revenue estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 6 | 3 | 6 | 6 |
Avg. Estimate | 26.76M | 27.63M | 113.84M | 114.02M |
Low estimate | 24M | 27M | 111M | 102.2M |
High estimate | 31.45M | 28.5M | 118.54M | 124.6M |
Year ago sales | 28.63M | 29.35M | 108.1M | 113.84M |
Sales growth (year/est) | -6.50% | -5.90% | 5.30% | 0.20% |
Earnings history | 30/03/2023 | 29/06/2023 | 29/09/2023 | 30/12/2023 |
---|
Est. EPS | -0.05 | -0.01 | 0.02 | 0.03 |
Actual EPS | 0.34 | 0.03 | -0.05 | -0.02 |
Difference | 0.39 | 0.04 | -0.07 | -0.05 |
Surprise % | 780.00% | 400.00% | -350.00% | -166.70% |
EPS trend | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
Current estimate | -0.02 | -0.03 | -0.05 | 0.07 |
7 days ago | -0.02 | -0.03 | -0.05 | 0.07 |
30 days ago | -0.02 | -0.03 | -0.06 | 0.05 |
60 days ago | -0.02 | -0.03 | -0.06 | 0.05 |
90 days ago | 0.04 | 0 | 0.03 | 0.32 |
EPS revisions | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | MEDXF | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | -105.90% | N/A | N/A | N/A |
Next qtr. | -200.00% | N/A | N/A | N/A |
Current year | -183.30% | N/A | N/A | N/A |
Next year | 240.00% | N/A | N/A | N/A |
Next 5 years (per annum) | N/A | N/A | N/A | N/A |
Past 5 years (per annum) | N/A | N/A | N/A | N/A |